Sudarshan Pharma Industries Limited (BOM:543828)
28.77
-0.24 (-0.83%)
At close: Jul 15, 2025
BOM:543828 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 5.51 | 1.44 | 117.19 | 2.36 | 12.55 | Upgrade |
Short-Term Investments | 15 | 15 | - | - | - | Upgrade |
Cash & Short-Term Investments | 20.51 | 16.44 | 117.19 | 2.36 | 12.55 | Upgrade |
Cash Growth | 24.76% | -85.97% | 4865.47% | -81.19% | -1.09% | Upgrade |
Accounts Receivable | 1,602 | 1,225 | 815.09 | 734.77 | 603.94 | Upgrade |
Other Receivables | 9.42 | 77.16 | 6.1 | 2.69 | 2.32 | Upgrade |
Receivables | 1,657 | 1,303 | 929.89 | 737.46 | 606.26 | Upgrade |
Inventory | 1,405 | 857.41 | 745.68 | 468.7 | 239.64 | Upgrade |
Prepaid Expenses | 20.31 | 17.84 | 4.76 | 1.82 | 6.48 | Upgrade |
Other Current Assets | 245.71 | 177.89 | 188.71 | 85.46 | 11.5 | Upgrade |
Total Current Assets | 3,348 | 2,372 | 1,986 | 1,296 | 876.44 | Upgrade |
Property, Plant & Equipment | 260.91 | 224.1 | 190.03 | 68.84 | 59.8 | Upgrade |
Long-Term Investments | 288.4 | 123.41 | 123.41 | 0.02 | 0.02 | Upgrade |
Goodwill | 34.88 | 43.59 | - | - | - | Upgrade |
Other Intangible Assets | 3.31 | 6.15 | 8.97 | 1.19 | 2.33 | Upgrade |
Other Long-Term Assets | 77.32 | 51.18 | 5.85 | 0.49 | 54.02 | Upgrade |
Total Assets | 4,024 | 2,831 | 2,325 | 1,375 | 992.6 | Upgrade |
Accounts Payable | 918.33 | 567.15 | 918.89 | 737.51 | 442.18 | Upgrade |
Accrued Expenses | 8.66 | 44.29 | 29.1 | 24.25 | - | Upgrade |
Short-Term Debt | 1,566 | 905.59 | 183.52 | 235.92 | 213.84 | Upgrade |
Current Portion of Long-Term Debt | 36.85 | 37.87 | 29.63 | 20.6 | 30.66 | Upgrade |
Current Income Taxes Payable | 51.75 | 24.36 | 6.4 | 3.26 | 2.8 | Upgrade |
Other Current Liabilities | 15.49 | 25.65 | 17.22 | 4.7 | 22.74 | Upgrade |
Total Current Liabilities | 2,597 | 1,605 | 1,185 | 1,026 | 712.22 | Upgrade |
Long-Term Debt | 104.6 | 104.91 | 127.88 | 49.4 | 53.21 | Upgrade |
Long-Term Deferred Tax Liabilities | 2.86 | 0.18 | 1.8 | 1.41 | 1.37 | Upgrade |
Other Long-Term Liabilities | 3.54 | 3.48 | 0.09 | 0.11 | 0.07 | Upgrade |
Total Liabilities | 2,709 | 1,714 | 1,315 | 1,077 | 767.05 | Upgrade |
Common Stock | 240.66 | 240.66 | 240.66 | 97.49 | 95.47 | Upgrade |
Additional Paid-In Capital | 578.08 | 578.1 | 578.1 | 79.66 | 61.48 | Upgrade |
Retained Earnings | 457.86 | 298.31 | 190.97 | 120.61 | 68.13 | Upgrade |
Comprehensive Income & Other | 38.21 | - | - | - | -0 | Upgrade |
Total Common Equity | 1,315 | 1,117 | 1,010 | 297.75 | 225.07 | Upgrade |
Minority Interest | 0.01 | - | - | - | 0.48 | Upgrade |
Shareholders' Equity | 1,315 | 1,117 | 1,010 | 297.75 | 225.56 | Upgrade |
Total Liabilities & Equity | 4,024 | 2,831 | 2,325 | 1,375 | 992.6 | Upgrade |
Total Debt | 1,707 | 1,048 | 341.04 | 305.92 | 297.71 | Upgrade |
Net Cash (Debt) | -1,687 | -1,032 | -223.85 | -303.56 | -285.16 | Upgrade |
Net Cash Per Share | -6.98 | -4.32 | -0.93 | -2.11 | -1.87 | Upgrade |
Filing Date Shares Outstanding | 240.66 | 240.66 | 240.66 | 166.78 | 143.2 | Upgrade |
Total Common Shares Outstanding | 240.66 | 240.66 | 240.66 | 146.23 | 143.2 | Upgrade |
Working Capital | 751.53 | 767.29 | 801.45 | 269.55 | 164.22 | Upgrade |
Book Value Per Share | 5.46 | 4.64 | 4.20 | 2.04 | 1.57 | Upgrade |
Tangible Book Value | 1,277 | 1,067 | 1,001 | 296.56 | 222.75 | Upgrade |
Tangible Book Value Per Share | 5.30 | 4.44 | 4.16 | 2.03 | 1.56 | Upgrade |
Land | 104.73 | 104.73 | 104.73 | 3.21 | - | Upgrade |
Buildings | 15.3 | 15.3 | 14.77 | 14.77 | 14.77 | Upgrade |
Machinery | 122.53 | 116.67 | 92.14 | 62.9 | 57.54 | Upgrade |
Construction In Progress | 60.41 | 18.8 | 0.12 | 5.36 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.